HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$5.51
Day range
$5.29 - $5.54
Year range
$1.33 - $6.88
Market cap
976.08M USD
Avg Volume
2.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.99M | 8.54% |
Net income | -15.72M | -4.54% |
Net profit margin | — | — |
Earnings per share | -0.09 | 18.18% |
EBITDA | -17.97M | -9.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 208.91M | 64.85% |
Total assets | 219.59M | 56.40% |
Total liabilities | 22.80M | 50.28% |
Total equity | 196.79M | — |
Shares outstanding | 180.09M | — |
Price to book | 5.01 | — |
Return on assets | -19.95% | — |
Return on capital | -21.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.72M | -4.54% |
Cash from operations | -13.25M | -44.66% |
Cash from investing | -3.38M | -121.98% |
Cash from financing | 1.06M | 1,230.85% |
Net change in cash | -15.57M | -333.00% |
Free cash flow | -7.55M | -122.47% |
About
Founded
2014
Headquarters
Website
Employees
39
